AC
MGNX icon

Athanor Capital’s MacroGenics MGNX Stock Holding History

Athanor Capital’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,597
Closed -$274K – 635
2021
Q1 		$274K Sell
8,597
-12,161
-59% -$295K 0.01% 612
2020
Q4 		$475K Buy
20,758
+8,495
+69% +$196K 0.01% 482
2020
Q3 		$309K Buy
+12,263
New +$335K 0.01% 421

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Athanor Capital's MGNX Position: Q2 2021 in Review

Athanor Capital sold out of MacroGenics (MGNX) in Q2 2021, closing a stake of 8,597 shares — an estimated $274K sold.

Athanor Capital first reported a position in MGNX in Q3 2020 and held it in 3 quarters. The position peaked at $475K in Q4 2020. 149 funds tracked by Wall St. Rank hold MGNX as of Q2 2021.

  • Athanor Capital reported no remaining MacroGenics position as of Q2 2021 after selling out during the quarter.
  • Athanor Capital sold 8,597 MacroGenics shares in Q2 2021, an estimated $274K.
  • Athanor Capital first reported a position in MacroGenics in Q3 2020 and held it in 3 quarters.
  • Athanor Capital's MacroGenics position peaked at $475K in Q4 2020.
  • 149 funds tracked by Wall St. Rank held MacroGenics as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.